🔎 Trials Near Me

Hem › Parkinsons sjukdom › Washington

Kliniska studier för Parkinsons sjukdom i Washington

15 studier för Parkinsons sjukdom söker deltagare vid platser i Washington.

Städer i Washington

Officiell studietext (engelska)

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

  • EvergreenHealth, Kirkland
  • Inland Northwest Research, Spokane
RekryterarFas 2
Ålder 40 till 80 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06680830

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

  • Site-007, Bellevue
  • Site-019, Seattle
RekryterarFas 2/3
Ålder 40 till 80 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06976268

A Study of Buntanetap in Participants With PD

  • Inland Northwest Research, Spokane
RekryterarFas 2/3
Ålder 40 till 85 · Alla kön · Uppdaterad 21 sep. 2026 · NCT07284784

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

  • Inland Northwest Research, Spokane
RekryterarFas 2
Ålder 40 till 80 · Alla kön · Uppdaterad 21 sep. 2026 · NCT07005180

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

  • Evergreen Health, Kirkland
  • Virginia Mason Medical Center, Seattle
  • University of Washington Medical Center, Seattle
  • och 1 fler
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT02071134

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

  • Vima Site #023, Kirkland
  • Vima Site #015, Spokane
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 11 sep. 2026 · NCT07804615

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

  • EvergreenHealth (Site #219), Kirkland
RekryterarFas 2
Ålder 30 till 80 · Alla kön · Uppdaterad 10 sep. 2026 · NCT07432958

Parkinson's Foundation PD GENEration Genetic Registry

  • Evergreen Health, Kirkland
  • Inland Northwest Research, Spokane
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT04994015

A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

  • VA Puget Sound Health Care System, Seattle
RekryterarObservationsstudie
Ålder 45 till 75 · Alla kön · Uppdaterad 4 sep. 2026 · NCT07330258

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

  • EvergreenHealth - Research Department, Kirkland
RekryterarFas 3
Ålder 45 till 75 · Alla kön · Uppdaterad 4 aug. 2026 · NCT06944522

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

  • Univ of Washington and VA Puget Sound Health Care System, Seattle
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 30 och äldre · Alla kön · Uppdaterad 27 juli 2026 · NCT04477785

Use of CereGate Therapy for Freezing of Gait in PD

  • University of Washington, Seattle
Rekryterar
Ålder 21 till 80 · Alla kön · Uppdaterad 28 maj 2026 · NCT05292794

A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

  • Evergreen Health Research, Kirkland
  • Inland Northwest Research, Spokane
RekryterarFas 1Friska volontärer välkomna
Ålder 30 till 85 · Alla kön · Uppdaterad 20 apr. 2026 · NCT06809400

The Parkinson's Genetic Research Study

  • VA Puget Sound Health Care System, Seattle
  • University of Washington, Seattle
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 14 maj 2024 · NCT01558479

Modifiable Variables in Parkinsonism (MVP)

  • Bastyr University, Kenmore
RekryterarObservationsstudie
Ålder 19 och äldre · Alla kön · Uppdaterad 25 mars 2022 · NCT02194816

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.